Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
826.00    -23.00 (-2.71%)
Bid:
827.50
Ask:
830.00
Spread: 2.50 (0.302%)
Market Cap: £951.34m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Director/PDMR Shareholding

20 Dec 2022 16:15

RNS Number : 3757K
Kainos Group plc
20 December 2022
Β 

20 December 2022

Kainos Group plc

("Kainos" or the "Company")

Β 

Director / PDMR shareholdings

The Company was notified on 20 December 2022 that Mary Catherine Davis, Non-Executive Director, purchased 6,400 shares in the Company at an aggregated average price of Β£15.6388.

Following this notification, Mary Catherine Davis has a reportable shareholding of 6,400 ordinary share in the issued share capital of the Company, constituting 0.00514% of the issued share capital of the Company.

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Mary Catherin Davis

2.

Reason for the notification

a.

Position/status

Non-Executive Director

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of Β£0.005 each

Β 

Β 

KNOS

b.

Nature of the transaction

Purchase of Ordinary Shares

c.

Price(s) and volume(s)

Price(s)

Volume(s)

Β£15.6388

6,400

d.

Aggregated information

Β· Aggregated volume

Β· Price

Β 

N/A

e.

Date of the transaction

20-December-2022

f.

Place of the transaction

LSE Regulated Market - XLON

Β 

Β 

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47Β 

Β 

Ends

Β 

For further information, please contact:

Β 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Β 

Investec Bank plc +44Β 20 7597 5970

Patrick Robb / Ben Griffiths

Β 

Canaccord Genuity +44 20 7523 4606

Simon Bridges / Emma Gabriel

Β 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Dwight Burden / Kwaku Aning

Β 

Β 

About Kainos

Kainos Group plc is a UK-headquartered IT provider with expertise across three divisions -Β Digital Services, Workday Services, and Workday Products.

Β 

Our Digital Services division develops and supports custom digital service platforms for public sector, commercial, and healthcare customers. Our solutions transform the delivery of these services, ensuring they are secure, accessible, and cost-effective, and provide better outcomes for users.Β 

Β 

Our Workday Services division specialises in the deployment of Workday Inc.'s Finance, HR and Planning products to leading organisations across Europe and North America. We are one of Workday's most respected partners, experienced in complex deployment and trusted by our customers to launch, test, expand, and support their Workday systems.

Β 

Our Workday Products division develops products that complement Workday. Our Smart product suite, includingΒ Smart TestΒ (for automated testing),Β Smart AuditΒ (for compliance monitoring), andΒ Smart ShieldΒ (for data masking), are used by more than 350 customers globally to safeguard their Workday systems.

Β 

Our people are central to our success. We employ more than 2,900 people in 22 countries across Europe and the Americas.Β 

Β 

We are listed on the London Stock Exchange (LSE: KNOS) and you can discover more about us atΒ www.kainos.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBKKBDABDDQBB
Date   Source Headline
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202612:45 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
1st Dec 20259:27 amRNSTotal Voting Rights
27th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 202511:39 amRNSDirector/PDMR shareholdings
24th Nov 202511:22 amRNSNotification of Major Holdings
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:50 amRNSRenewal of Share Buyback Programme
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20252:57 pmRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 202512:49 pmRNSDirector / PDMR shareholdings
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSInterim results
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202511:03 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.